October 30, 2026

Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026

From Diagnexia on LinkedIn: Delighted to share that Diagnexia has been shortlisted for Health Tech Product of the Year at the LaingBuisson Awards 2026. A huge congratulations to our incredible team and partners for driving innovation and excellence every day....

recent articles

Originally published on KevinMD.com by Dr. Michael Misialek, a practicing pathologist in Massachusetts.   As a pathologist, I recognize the importance of every diagnosis. Behind each slide is a patient, a family, a network of family and...

Visit Definiens at booth #423 at the Molecular Med-Tri-Con conference, February 16-18 to learn about Definiens’ comprehensive range of digital and molecular pathology solutions for imaging and quantifying biomarkers in tissue sections. At...

PathXL has today launched a next generation tablet version for PathXL Tutor that delivers a broad range of new capabilities to the marketplace. This new product was developed in a close working partnership with the University of...

Thanks to everyone who participated in our recent draw for a 6 month license of microDimensions Voloom! The winner of a free license for Voloom, the fastest and most versatile software for histology 3D reconstruction, has been drawn. Among all...

  Date: Thursday, January 29th Time: 10am - 11am CST | 4pm - 5pm GMT   Prof. Peter Hamilton | VP Research and Development, PathXL Eileen Regan | Head of Account Management and Pre-Sales Empower your...

Carlsbad, CA. - January 21, 2015 - Applied Spectral Imaging (ASI, www.spectral-imaging.com) announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its GenASIs HiPath image capture and analysis...

OR

platinum partners

gold partners

Silver Partners

Media Partners